Personal information

Websites & social links

Website

Other IDs

Loop profile: 2186258
Scopus Author ID: 55931565500

Activities

Collapse all

Employment (3)

Erasmus MC: Rotterdam, Zuid-Holland, NL

2018-07-01 to present | PostDoc (Medical Oncology)
Employment
Source: Self-asserted source
Hayri E Balcioglu

National University of Singapore Mechanobiology Institute: Singapore, SG

2016-04-01 to 2018-03-31 | Research Fellow
Employment
Source: Self-asserted source
Hayri E Balcioglu

Leiden University: Leiden, NL

2010-10-01 to 2016-03-31 | PhD Student (Toxicology)
Employment
Source: Self-asserted source
Hayri E Balcioglu

Education and qualifications (1)

Universiteit Leiden: Leiden, Zuid-Holland, NL

2010-10-01 to 2016-03-08 | PhD (Toxicology)
Education
Source: Self-asserted source
Hayri E Balcioglu

Works (50 of 61)

Items per page:
Page 1 of 2

Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma

Nature Communications
2025-01-29 | Journal article
DOI: 10.1038/s41467-025-56441-5
Contributors: Levi van Hijfte; Marjolein Geurts; Iris de Heer; Santoesha A. Ghisai; Hayri E. Balcioglu; Youri Hoogstrate; Wies R. Vallentgoed; Rania Head; Rosa Luning; Thierry van den Bosch et al.
Source: check_circle
Crossref

Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer

Nature Communications
2024 | Journal article
DOI: 10.1038/s41467-024-45714-0
EID:

2-s2.0-85185111038

Part of ISSN: 20411723
Contributors: Rijnders, M.; Nakauma-González, J.A.; Robbrecht, D.G.J.; Gil-Jimenez, A.; Balcioglu, H.E.; Oostvogels, A.A.M.; Aarts, M.J.B.; Boormans, J.L.; Hamberg, P.; van der Heijden, M.S. et al.
Source: Self-asserted source
Hayri E Balcioglu via Scopus - Elsevier
grade
Preferred source (of 2)‎

Lipid-based nanosystems: the next generation of cancer immune therapy

Journal of Hematology and Oncology
2024 | Journal article
DOI: 10.1186/s13045-024-01574-1
EID:

2-s2.0-85199029726

Part of ISSN: 17568722
Contributors: Cheng, Z.; Fobian, S.-F.; Gurrieri, E.; Amin, M.; D’Agostino, V.G.; Falahati, M.; Zalba, S.; Debets, R.; Garrido, M.J.; Saeed, M. et al.
Source: Self-asserted source
Hayri E Balcioglu via Scopus - Elsevier

CLEAR-IT: Contrastive Learning to Capture the Immune Composition of Tumor Microenvironments

2024-08-20 | Preprint
DOI: 10.1101/2024.08.20.608738
Contributors: Daniel Spengler; Serafim Korovin; Kirti Prakash; Peter Bankhead; Reno Debets; Carlas Smith; Hayri E. Balcioglu
Source: check_circle
Crossref

TME-analyzer: a new interactive and dynamic image analysis tool that identified immune cell distances as predictors for survival of triple negative breast cancer patients

npj Imaging
2024-07-25 | Journal article
DOI: 10.1038/s44303-024-00022-6
Part of ISSN: 2948-197X
Contributors: Hayri E. Balcioglu; Rebecca Wijers; Marcel Smid; Dora Hammerl; Anita M. Trapman-Jansen; Astrid Oostvogels; Mieke Timmermans; John W. M. Martens; Reno Debets
Source: Self-asserted source
Hayri E Balcioglu via Crossref Metadata Search

A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer

Cancer Immunology, Immunotherapy
2023 | Journal article
DOI: 10.1007/s00262-022-03250-0
EID:

2-s2.0-85136949199

Part of ISSN: 14320851 03407004
Contributors: Rijnders, M.; Robbrecht, D.G.J.; Oostvogels, A.A.M.; van Brakel, M.; Boormans, J.L.; Aarts, M.J.B.; Balcioglu, H.E.; Hamberg, P.; Voortman, J.; Westgeest, H.M. et al.
Source: Self-asserted source
Hayri E Balcioglu via Scopus - Elsevier

Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase

Cells
2023 | Journal article
DOI: 10.3390/cells12081185
EID:

2-s2.0-85154540804

Part of ISSN: 20734409
Contributors: Roelofs, P.A.; Timmermans, M.A.M.; Stefanovska, B.; den Boestert, M.A.; van den Borne, A.W.M.; Balcioglu, H.E.; Trapman, A.M.; Harris, R.S.; Martens, J.W.M.; Span, P.N.
Source: Self-asserted source
Hayri E Balcioglu via Scopus - Elsevier
grade
Preferred source (of 3)‎

Frequency of Peripheral CD8+ T Cells Expressing Chemo-Attractant Receptors CCR1, 4 and 5 Increases in NPC Patients with EBV Clearance upon Radiotherapy

Cancers
2023 | Journal article
DOI: 10.3390/cancers15061887
EID:

2-s2.0-85151452880

Part of ISSN: 20726694
Contributors: Mahajan, S.; Balcioglu, H.E.; Oostvogels, A.; Dik, W.A.; Chan, K.C.A.; Lo, K.-W.; Hui, E.P.; Tsang, A.; Tong, J.; Lam, W.K.J. et al.
Source: Self-asserted source
Hayri E Balcioglu via Scopus - Elsevier
grade
Preferred source (of 3)‎

GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches

Frontiers in Oncology
2023 | Journal article
DOI: 10.3389/fonc.2023.1199432
EID:

2-s2.0-85171275491

Part of ISSN: 2234943X
Contributors: Verhoeven, M.; Ruigrok, E.A.M.; van Leenders, G.J.L.H.; van den Brink, L.; Balcioglu, H.E.; van Weerden, W.M.; Dalm, S.U.
Source: Self-asserted source
Hayri E Balcioglu via Scopus - Elsevier

Data from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6530805
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Data from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6530805.v1
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 1 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482048.v1
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 1 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482048
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 2 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482045
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 2 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482045.v1
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 3 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482042
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 3 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482042.v1
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 4 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482036
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 4 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482036.v1
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 5 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482033
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 5 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482033.v1
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 6 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482030.v1
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 6 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482030
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 7 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482027.v1
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 7 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482027
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 8 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482024.v1
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 8 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482024
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 9 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482021.v1
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure 9 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482021
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure legends from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482018
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary figure legends from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482018.v1
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary table 1 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482015.v1
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary table 1 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482015
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary table 2 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482009.v1
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

Supplementary table 2 from Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>+</sup> T cells

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22482009
Contributors: Maud Rijnders; Hayri E. Balcioglu; Debbie G.J. Robbrecht; Astrid A.M. Oostvogels; Rebecca Wijers; Maureen J.B. Aarts; Paul Hamberg; Geert J.L.H. van Leenders; J. Alberto Nakauma-González; Jens Voortman et al.
Source: check_circle
Crossref

3D-Engineered Scaffolds to Study Microtubes and Localization of Epidermal Growth Factor Receptor in Patient-Derived Glioma Cells

Small
2022 | Journal article
DOI: 10.1002/smll.202204485
EID:

2-s2.0-85139484985

Part of ISSN: 16136829 16136810
Contributors: Barin, N.; Balcioglu, H.E.; de Heer, I.; de Wit, M.; Lamfers, M.L.M.; van Royen, M.E.; French, P.J.; Accardo, A.
Source: Self-asserted source
Hayri E Balcioglu via Scopus - Elsevier

Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8<sup>þ</sup> T cells

Clinical Cancer Research
2022 | Journal article
DOI: 10.1158/1078-0432.CCR-20-3319
EID:

2-s2.0-85123118253

Part of ISSN: 15573265 10780432
Contributors: Rijnders, M.; Balcioglu, H.E.; Robbrecht, D.G.J.; Oostvogels, A.A.M.; Wijers, R.; Aarts, M.J.B.; Hamberg, P.; van Leenders, G.J.L.H.; Nakauma-González, J.A.; Voortman, J. et al.
Source: Self-asserted source
Hayri E Balcioglu via Scopus - Elsevier
grade
Preferred source (of 2)‎

Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer Patients

Cancers
2022 | Journal article
DOI: 10.3390/cancers14174298
EID:

2-s2.0-85137752585

Part of ISSN: 20726694
Contributors: Phanthunane, C.; Wijers, R.; De Herdt, M.J.; Koljenović, S.; Sleijfer, S.; Baatenburg de Jong, R.J.; Hardillo, J.A.U.; Debets, R.; Balcioglu, H.E.
Source: Self-asserted source
Hayri E Balcioglu via Scopus - Elsevier
grade
Preferred source (of 3)‎

Substrate rigidity modulates traction forces and stoichiometry of cell-matrix adhesions

Journal of Chemical Physics
2022 | Journal article
DOI: 10.1063/5.0077004
EID:

2-s2.0-85125585344

Part of ISSN: 10897690 00219606
Contributors: Balcioglu, H.E.; Harkes, R.; Danen, E.H.J.; Schmidt, T.
Source: Self-asserted source
Hayri E Balcioglu via Scopus - Elsevier
grade
Preferred source (of 2)‎

T Cell-to-Stroma Enrichment (TSE) score: a gene expression metric that predicts response to immune checkpoint inhibitors in patients with urothelial cancer

bioRxiv
2022 | Other
DOI: 10.1101/2022.05.30.493997
EID:

2-s2.0-85172231029

Part of ISSN: 26928205
Contributors: Rijnders, M.; Nakauma-González, J.A.; Robbrecht, D.G.J.; Gil-Jimenez, A.; Balcioglu, H.E.; Oostvogels, A.A.M.; Aarts, M.J.B.; Boormans, J.L.; Hamberg, P.; van der Heijden, M.S. et al.
Source: Self-asserted source
Hayri E Balcioglu via Scopus - Elsevier

Comparative single-cell RNA-sequencing profiling of BMP4-treated primary glioma cultures reveals therapeutic markers.

Neuro-oncology
2022-05-26 | Journal article
DOI: 10.1093/neuonc/noac143
PMID: 35639831
Source: Self-asserted source
Hayri E Balcioglu
grade
Preferred source (of 2)‎

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer

Nature Communications
2021 | Journal article
DOI: 10.1038/s41467-021-25962-0
EID:

2-s2.0-85115813215

Part of ISSN: 20411723
Contributors: Hammerl, D.; Martens, J.W.M.; Timmermans, M.; Smid, M.; Trapman-Jansen, A.M.; Foekens, R.; Isaeva, O.I.; Voorwerk, L.; Balcioglu, H.E.; Wijers, R. et al.
Source: Self-asserted source
Hayri E Balcioglu via Scopus - Elsevier

Substrate rigidity modulates traction forces and stoichiometry of cell matrix adhesions

bioRxiv
2021 | Other
DOI: 10.1101/2021.10.29.466476
EID:

2-s2.0-85119879216

Part of ISSN: 26928205
Contributors: Balcioglu, H.E.; Harkes, R.; Danen, E.H.J.; Schmidt, T.
Source: Self-asserted source
Hayri E Balcioglu via Scopus - Elsevier
grade
Preferred source (of 2)‎

V-domain ig suppressor of t cell activation (Vista) expression is an independent prognostic factor in multiple myeloma

Cancers
2021 | Journal article
DOI: 10.3390/cancers13092219
EID:

2-s2.0-85105143175

Part of ISSN: 20726694
Contributors: Mutsaers, P.; Balcioglu, H.E.; Kuiper, R.; Hammerl, D.; Wijers, R.; van Duin, M.; van der Holt, B.; Broijl, A.; Gregory, W.; Zweegman, S. et al.
Source: Self-asserted source
Hayri E Balcioglu via Scopus - Elsevier
grade
Preferred source (of 3)‎

B-cell clusters at the invasive margin associate with longer survival in early-stage oral-tongue cancer patients.

Oncoimmunology
2021-02 | Journal article
DOI: 10.1080/2162402x.2021.1882743
PMID: 33643695
PMC: PMC7894457
Contributors: Phanthunane C; Wijers R; de Herdt M; Langeveld TPM; Koljenovic S; Dasgupta S; Sleijfer S; Baatenburg de Jong RJ; Hardillo J; Balcioglu HE et al.
Source: Self-asserted source
Hayri E Balcioglu via Europe PubMed Central
grade
Preferred source (of 2)‎

A subtle relationship between substrate stiffness and collective migration of cell clusters

Soft Matter
2020 | Journal article
DOI: 10.1039/C9SM01893J
Contributors: Hayri E. Balcioglu; Lakshmi Balasubramaniam; Tomita Vasilica Stirbat; Bryant L. Doss; Marc-Antoine Fardin; René-Marc Mège; Benoit Ladoux
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

CD45RA<sup>+</sup>CCR7<sup>-</sup> CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab.

Journal for immunotherapy of cancer
2019-06 | Journal article
DOI: 10.1186/s40425-019-0608-y
PMID: 31176366
PMC: PMC6555948
Contributors: Kunert A; Basak EA; Hurkmans DP; Balcioglu HE; Klaver Y; van Brakel M; Oostvogels AAM; Lamers CHJ; Bins S; Koolen SLW et al.
Source: Self-asserted source
Hayri E Balcioglu via Europe PubMed Central
grade
Preferred source (of 2)‎

FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling Pathway.

Cancers
2019-06 | Journal article
DOI: 10.3390/cancers11060836
PMID: 31213005
PMC: PMC6627937
Contributors: Yeo MS; Subhash VV; Suda K; Balcıoğlu HE; Zhou S; Thuya WL; Loh XY; Jammula S; Peethala PC; Tan SH et al.
Source: Self-asserted source
Hayri E Balcioglu via Europe PubMed Central
grade
Preferred source (of 3)‎

P130Cas contributes to cellular mechanosensing and force exertion

bioRxiv
2018 | Other
DOI: 10.1101/371021
EID:

2-s2.0-85094080052

Part of ISSN: 26928205
Contributors: van Hoorn, H.; Donato, D.M.; Balcioglu, H.E.; Danen, E.H.; Schmidt, T.
Source: Self-asserted source
Hayri E Balcioglu via Scopus - Elsevier
grade
Preferred source (of 2)‎

Cytoskeletal Anisotropy Controls Geometry and Forces of Adherent Cells.

Physical review letters
2018-10-01 | Journal article
DOI: 10.1103/physrevlett.121.178101
PMID: 30411958
Source: Self-asserted source
Hayri E Balcioglu
Items per page:
Page 1 of 2
How many people are using ORCID?